Swiss National Bank’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.74M | Hold |
117,900
| – | – | ﹤0.01% | 1513 |
|
|
2025
Q4 | $3.2M | Buy |
117,900
+2,100
| +2% | +$55.3K | ﹤0.01% | 1613 |
|
|
2025
Q3 | $3M | Buy |
115,800
+1,700
| +1% | +$39.4K | ﹤0.01% | 1632 |
|
|
2025
Q2 | $2.32M | Sell |
114,100
-1,600
| -1% | -$31.1K | ﹤0.01% | 1712 |
|
|
2025
Q1 | $2.1M | Sell |
115,700
-1,600
| -1% | -$35.7K | ﹤0.01% | 1732 |
|
|
2024
Q4 | $2.96M | Buy |
117,300
+1,400
| +1% | +$38K | ﹤0.01% | 1626 |
|
|
2024
Q3 | $3.94M | Buy |
115,900
+1,600
| +1% | +$61K | ﹤0.01% | 1469 |
|
|
2024
Q2 | $4.23M | Hold |
114,300
| – | – | ﹤0.01% | 1373 |
|
|
2024
Q1 | $4.8M | Buy |
114,300
+17,300
| +18% | +$710K | ﹤0.01% | 1327 |
|
|
2023
Q4 | $3.85M | Buy |
97,000
+8,700
| +10% | +$256K | ﹤0.01% | 1447 |
|
|
2023
Q3 | $2.43M | Buy |
88,300
+900
| +1% | +$28.2K | ﹤0.01% | 1710 |
|
|
2023
Q2 | $2.97M | Buy |
87,400
+6,000
| +7% | +$202K | ﹤0.01% | 1633 |
|
|
2023
Q1 | $2.93M | Sell |
81,400
-8,900
| -10% | -$384K | ﹤0.01% | 1600 |
|
|
2022
Q4 | $4.02M | Buy |
90,300
+2,100
| +2% | +$75K | ﹤0.01% | 1454 |
|
|
2022
Q3 | $2.48M | Hold |
88,200
| – | – | ﹤0.01% | 1723 |
|
|
2022
Q2 | $2.38M | Hold |
88,200
| – | – | ﹤0.01% | 1794 |
|
|
2022
Q1 | $3M | Buy |
88,200
+6,300
| +8% | +$201K | ﹤0.01% | 1783 |
|
|
2021
Q4 | $3.17M | Sell |
81,900
-3,400
| -4% | -$148K | ﹤0.01% | 1761 |
|
|
2021
Q3 | $4.61M | Sell |
85,300
-1,900
| -2% | -$89.2K | ﹤0.01% | 1517 |
|
|
2021
Q2 | $2.92M | Sell |
87,200
-3,200
| -4% | -$87.8K | ﹤0.01% | 1850 |
|
|
2021
Q1 | $1.86M | Buy |
90,400
+1,900
| +2% | +$43.6K | ﹤0.01% | 2041 |
|
|
2020
Q4 | $1.55M | Buy |
+88,500
| New | +$1.59M | ﹤0.01% | 2059 |
|
|
2018
Q2 | – | Sell |
-15,453
| Closed | -$540K | – | 2527 |
|
|
2018
Q1 | $540K | Buy |
15,453
+1,873
| +14% | +$72.6K | ﹤0.01% | 2350 |
|
|
2017
Q4 | $579K | Hold |
13,580
| – | – | ﹤0.01% | 2363 |
|
|
2017
Q3 | $583K | Hold |
13,580
| – | – | ﹤0.01% | 2328 |
|
|
2017
Q2 | $503K | Buy |
13,580
+2,920
| +27% | +$129K | ﹤0.01% | 2411 |
|
|
2017
Q1 | $577K | Hold |
10,660
| – | – | ﹤0.01% | 2321 |
|
|
2016
Q4 | $566K | Hold |
10,660
| – | – | ﹤0.01% | 2334 |
|
|
2016
Q3 | $646K | Hold |
10,660
| – | – | ﹤0.01% | 2223 |
|
|
2016
Q2 | $702K | Hold |
10,660
| – | – | ﹤0.01% | 2169 |
|
|
2016
Q1 | $583K | Buy |
10,660
+1,993
| +23% | +$224K | ﹤0.01% | 2218 |
|
|
2015
Q4 | $2.04M | Hold |
8,667
| – | – | ﹤0.01% | 1333 |
|
|
2015
Q3 | $1.37M | Buy |
8,667
+1,200
| +16% | +$340K | ﹤0.01% | 1566 |
|
|
2015
Q2 | $2.83M | Buy |
7,467
+60
| +0.8% | +$23.8K | 0.01% | 1110 |
|
|
2015
Q1 | $3.1M | Buy |
7,407
+847
| +13% | +$303K | 0.01% | 1032 |
|
|
2014
Q4 | $1.8M | Buy |
6,560
+153
| +2% | +$38K | 0.01% | 1333 |
|
|
2014
Q3 | $1.25M | Sell |
6,407
-113
| -2% | -$24.6K | ﹤0.01% | 1528 |
|
|
2014
Q2 | $1.6M | Buy |
6,520
+427
| +7% | +$96.4K | 0.01% | 1412 |
|
|
2014
Q1 | $1.61M | Buy |
6,093
+1,020
| +20% | +$391K | 0.01% | 1362 |
|
|
2013
Q4 | $1.84M | Buy |
5,073
+360
| +8% | +$139K | 0.01% | 1109 |
|
|
2013
Q3 | $2.5M | Sell |
4,713
-247
| -5% | -$84.7K | 0.01% | 881 |
|
|
2013
Q2 | $1.16M | Buy |
+4,960
| New | +$977K | 0.01% | 1319 |
|
Other funds holding CLDX
KCM
VCM
CC
EP